SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves better-than-expected quarterly results, raised outlook and strong AI-cloud demand have fueled a rally and talk of short covering. Traders are split over whether the large backlog and customer prepayments ease financing concerns or whether heavy debt, interest costs and capital spending still threaten sustainable cash flow.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is drawing attention after reports linking CEO Jensen Huang to a suspected Chinese spy and concerns about possible chip shipments to China intensified scrutiny of his leadership and export-control risks. Traders are divided over whether the controversy threatens the business, while many view the selloff as a buying opportunity ahead of earnings.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis quarterly results missed revenue and earnings expectations, and its revenue outlook came in below consensus, prompting concern about its high valuation and slow path to commercialization. Bears view the results as evidence that quantum revenue remains distant, while some bulls point to progress in processor fidelity and argue the company is a long-term technology bet.

Agility Robotics, Inc. engages in the builds robot partners that augment the human workforce. The firm groundbreaking general-purpose humanoid robot, digit, is the first multi-purpose, human-centric robot that is made for work and commercially deployed today. The company is headquartered in Salem, OR.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Traders are reacting to reports of a sharp IPO surge by humanoid-robotics rival Unitree, with some expecting renewed interest in AGLT by comparison. Others argue the enthusiasm overlooks Agilitys limited commercial scale, losses and de-SPAC risks.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is drawing attention ahead of its Q3 earnings, with traders focused on whether Northern Datas AI infrastructure business can drive revenue growth and whether the Anthropic compute agreement will translate into visible business. Bulls anticipate a beat and point to elevated short interest, while skeptics question financing, dilution and execution; squeeze talk remains speculation.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars selloff is being tied to analyst downgrades citing limited 2026 booking visibility, with rising yields and uncertainty around solar policy and tax credits adding pressure. Bears see continued weakness ahead, while some traders call the drop overdone given the companys contracted backlog and are buying the dip.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunrun is selling off amid renewed concern that higher interest rates will weigh on financing-dependent residential solar demand, with traders also citing pressure across solar stocks and short sellers. Some view the drop as overdone and point to Sunruns earnings and storage/AI-power opportunities, while others remain concerned about financing costs and the companys outlook.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Attention is centered on the pending Phase 3 APPROACH readout for Helus Pharmas HLP003 depression treatment, with traders weighing the binary clinical catalyst against financing and competitive risks. Bulls emphasize its add-on trial design and potential shorter clinic time, while skeptics question whether Phase 2 efficacy will hold up and whether recent research or Usonas reported NDA filing could weaken its case.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCrysts quarterly results beat expectations and lifted total revenue guidance, but the stocks weak response has fueled frustration and debate over whether the headline growth was helped by a temporary ORLADEYO inventory build while its product-specific outlook stayed unchanged. Traders are also focused on the Astria acquisitions dilution overhang and view upcoming Netherton and navenibart data as potential tests of the companys pipeline prospects.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A disappointing Q3 reportwith a surprise loss, weaker margins, fewer subscribers sequentially, and a lower profitability outlookhas driven HIMSs sharp selloff. Traders are debating whether the growth story and potential from weight-loss treatments and peptides can offset near-term concerns about profitability and subscriber trends, while some view the drop as a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
